search
Back to results

Evaluation of High Speed Laser Doppler Imaging Technology (HSL-DI)

Primary Purpose

Hay Fever

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Allergy test reading
Sponsored by
Centre Hospitalier Universitaire Vaudois
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Hay Fever

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • age 18 to 65 years
  • history of allergic rhinitis to birch pollen and/or grass pollen.

Exclusion Criteria:

  • any medical condition (including pregnancy) that could influence the study (viral or bacterial airway infection, active allergic rhinitis)
  • uncontrolled asthma (peak expiratory "flow" <80% of volunteer's best personal value)
  • treatment with antihistamine medication less than two weeks before enrolment or during the trial.

Sites / Locations

  • CHUV , Division of Immunology and Allergy

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Atopic volunteers

Arm Description

Allergy tests will be performed in allergic patients with rhinoconjunctivitis and allergy test reading measured following two different methodologies. 1) test reading based on conventional wheal and flare measurement (wheal diameter in mm, CWFM), 2) test reading based on high speed laser doppler imaging (HS-LDI). Both type of tests reading will be compared.

Outcomes

Primary Outcome Measures

Skin microcirculation flow changes over time (composite autcome)
Skin microcirculation flow changes will be evaluated at 2.5 min., 5 min., 7.5 min., 10 min., 12.5 min., 15 min., 17.5 min. and 20 min. as measured in a composite outcome 1) by HS-LDI based on parameter "area" corresponding to the total number of non-zero pixels in the flare area and parameter "flow" as measured according to a specific formula in arbitrary units, or 2) as measured by conventional wheal and flare measurement (CWFM, direct observer reading) in mm.

Secondary Outcome Measures

Full Information

First Posted
July 30, 2015
Last Updated
November 28, 2015
Sponsor
Centre Hospitalier Universitaire Vaudois
search

1. Study Identification

Unique Protocol Identification Number
NCT02619331
Brief Title
Evaluation of High Speed Laser Doppler Imaging Technology
Acronym
HSL-DI
Official Title
Evaluation of High Speed Laser Doppler Imaging Technology to Quantify Skin Prick Tests in Allergic Volunteers
Study Type
Interventional

2. Study Status

Record Verification Date
November 2015
Overall Recruitment Status
Completed
Study Start Date
February 2008 (undefined)
Primary Completion Date
December 2010 (Actual)
Study Completion Date
September 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Centre Hospitalier Universitaire Vaudois

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Skin prick tests (SPT) are commonly used in daily allergological practice to assess skin reactivity to allergens. Multiple factors can contribute to non-optimal results of conventional wheal and flare measurement (CWFM) of SPT such as inaccurate measurements, observer-dependency and absence of traceability. This study aims to evaluate the quantification of SPT by a novel High Speed Laser Doppler Imaging (HSL-DI) and to compare it with CWFM. First, SPT with birch and/or grass pollen extracts as well as positive and negative controls will be performed in 20 volunteers (11 atopics, 9 non-atopics) to establish the characteristics (cut-off, optimal reading time and allergen concentration) of HSL-DI analysis based on two parameters ("area" and "flow" measurement). In a second step, fifty patients will be tested with birch and grass pollen extracts at optimal allergen concentration and time window. Analysis of SPT by HSL-DI and CWFM will be compared.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hay Fever

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Atopic volunteers
Arm Type
Experimental
Arm Description
Allergy tests will be performed in allergic patients with rhinoconjunctivitis and allergy test reading measured following two different methodologies. 1) test reading based on conventional wheal and flare measurement (wheal diameter in mm, CWFM), 2) test reading based on high speed laser doppler imaging (HS-LDI). Both type of tests reading will be compared.
Intervention Type
Procedure
Intervention Name(s)
Allergy test reading
Intervention Description
Reading of allergy skin tests (in response to allergen extracts or histamine or negative control) by HSL-DI versus direct observer evaluation (CWFM)
Primary Outcome Measure Information:
Title
Skin microcirculation flow changes over time (composite autcome)
Description
Skin microcirculation flow changes will be evaluated at 2.5 min., 5 min., 7.5 min., 10 min., 12.5 min., 15 min., 17.5 min. and 20 min. as measured in a composite outcome 1) by HS-LDI based on parameter "area" corresponding to the total number of non-zero pixels in the flare area and parameter "flow" as measured according to a specific formula in arbitrary units, or 2) as measured by conventional wheal and flare measurement (CWFM, direct observer reading) in mm.
Time Frame
tests reading at 2.5 min., 5 min., 7.5 min., 10 min., 12.5 min., 15 min., 17.5 min. and 20 min.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: age 18 to 65 years history of allergic rhinitis to birch pollen and/or grass pollen. Exclusion Criteria: any medical condition (including pregnancy) that could influence the study (viral or bacterial airway infection, active allergic rhinitis) uncontrolled asthma (peak expiratory "flow" <80% of volunteer's best personal value) treatment with antihistamine medication less than two weeks before enrolment or during the trial.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
François Spertini, MD
Organizational Affiliation
CHUV
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHUV , Division of Immunology and Allergy
City
Lausanne
ZIP/Postal Code
1011
Country
Switzerland

12. IPD Sharing Statement

Learn more about this trial

Evaluation of High Speed Laser Doppler Imaging Technology

We'll reach out to this number within 24 hrs